Co-Authors
This is a "connection" page, showing publications co-authored by Hong Kim and Sang Park.
Connection Strength
0.561
-
Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill. 2015; 20(41).
Score: 0.152
-
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection. Emerg Infect Dis. 2021 01; 27(1).
Score: 0.057
-
Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection. Int J Infect Dis. 2018 Jul; 72:8-10.
Score: 0.048
-
Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med. 2018 03; 33(2):233-246.
Score: 0.047
-
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. Emerg Infect Dis. 2017 07; 23(7):1079-1084.
Score: 0.045
-
Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea. J Korean Med Sci. 2017 May; 32(5):744-749.
Score: 0.045
-
Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection. J Korean Med Sci. 2016 Nov; 31(11):1717-1725.
Score: 0.043
-
Viral Load Kinetics of MERS Coronavirus Infection. N Engl J Med. 2016 Sep 29; 375(13):1303-5.
Score: 0.043
-
Isolation of Middle East Respiratory Syndrome Coronavirus from a Patient of the 2015 Korean Outbreak. J Korean Med Sci. 2016 Feb; 31(2):315-20.
Score: 0.041
-
Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerg Infect Dis. 2015 Dec; 21(12):2186-9.
Score: 0.040